Introduction to Intellectual Property: A U.S. Perspective

• Published in: Cold Spring Harbor perspectives in medicine Vol. 5; no. 8; p. a020776
• Main Authors: Murphy, Amanda, Stramiello, Michael, Lewis, Stacy, Irving, Tom
• Format: Journal Article
• Language: English
• Published: United States Cold Spring Harbor Laboratory Press 01-08-2015
• Subjects: Biomedical Technology - legislation & jurisprudence; Copyright - legislation & jurisprudence; Humans; Intellectual Property; Patents as Topic - legislation & jurisprudence; Privacy - legislation & jurisprudence; United States; United States
• ISSN: 2472-5412
• DOI: 10.1101/cshperspect.a020776

This review introduces patents and trade secrets, the two mechanisms that U.S. law provides inventors to protect their inventions. These mechanisms are mutually exclusive: One demands disclosure and the other calls for concealment. Many biotechnology innovators opt for patents, which grant legal, time-limited monopolies to eligible inventions.To obtain a patent in the United States, an invention must be useful to the public and made or altered by the hand of man. It must then clear the hurdles of novelty and nonobviousness. If an invention can do that, obtaining a patent becomes a matter of form: Who qualifies as an inventor? Does the application demonstrate possession, stake a clear claim to the protection sought, and enable "ordinary" colleagues to replicate it? Has the inventor purposely withheld anything? This review addresses each of these hurdles as they apply to biotech inventions.